Sign in

CIK 0001743881 · Large accelerated filer

BridgeBio Pharma, Inc.

Sign in to watch
Ticker
BBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(650) 391-9740
Business address
3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
Former names
BridgeBio Pharma LLC
  1. 4 Planned sale Chief Accounting Officer sold 2,000 shares at $80.06 ($160,120)
  2. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  3. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  4. S-3ASR Offering Registration Statement
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 8-K Event Other events
  7. 4 Planned sale Director sold 17,167 shares at $84.00 ($1,442,028)
  8. 4 Planned sale Director sold 148,589 shares at an average $88.54 ($13,156,008)
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed · Bylaws or fiscal year change · Regulation FD disclosure
  13. 8-K Event Executive or director change · Shareholder vote results
  14. 4 Planned sale Director sold 39,363 shares at an average $69.92 ($2,752,270)
  15. 4 Planned sale Director sold 5,004 shares at an average $68.25 ($341,524)
  16. 4 Grant or award Director acquired 3,990 shares (grant or award)
  17. 4 Grant or award Director acquired 3,990 shares (grant or award)
  18. 4 Grant or award Director acquired 3,990 shares (grant or award)
  19. 4 Grant or award Director acquired 3,990 shares (grant or award)
  20. 4 Grant or award Director acquired 3,990 shares (grant or award)

Page 2 of 42 · 834 filings